MPDL3280A

atezolizumab · Genentech (licensed to Millennium or Roche portfolio; specific sponsor not stated)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MPDL3280A, covering 2019-07-05 to 2023-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC [Phase 2]